Welcome to Francis Academic Press

Academic Journal of Medicine & Health Sciences, 2023, 4(2); doi: 10.25236/AJMHS.2023.040208.

Advantages of Combined Chinese and Western Medicine in Treating Liver Cancer


Furong Cheng, Hailong Si

Corresponding Author:
Hailong Si

Shaanxi University of Chinese Medicine, Xianyang, 712046, Shaanxi, China


Primary liver cancer (abbreviated as hepatocellular carcinoma) is a malignant tumor occurring from intrahepatic bile duct cells or hepatocytes, which is one of the common malignant tumors in China. Early stage liver cancer is mainly treated by surgery, interventional therapy, local ablation therapy, immunotherapy, etc. However, most liver cancers are already in the middle and late stages when diagnosed, and western medical treatment has certain limitations; but at the same time, Chinese medicine treatment has certain advantages, which can improve postoperative status, enhance patients' immunity, improve patients' systemic symptoms, and help improve life quality. In this paper, we review the advantages of Western medical treatment combined with TCM in the treatment of primary hepatocellular carcinoma.


hepatocellular carcinoma; combined Chinese and Western medicine treatment; advantages

Cite This Paper

Furong Cheng, Hailong Si. Advantages of Combined Chinese and Western Medicine in Treating Liver Cancer. Academic Journal of Medicine & Health Sciences (2023) Vol. 4, Issue 2: 47-52. https://doi.org/10.25236/AJMHS.2023.040208.


[1] Wang N, Liu SH, Yang L, et al. 2018 Global Cancer Statistics Report Interpretation [J] Electronic Journal of Integrative Oncology, 2019, 5(1):87-97.

[2] Meng Younan, Zhao L, Liu Liu, Liu JJ. Research progress in the combination of Chinese and Western medicine for the prevention and treatment of primary liver cancer [J]. Journal of Traditional Chinese Medicine, 2021, 49(2):115-119.

[3] Shi Yangyue. Study on the rules of identification and treatment of primary liver cancer [D]. Nanjing University of Traditional Chinese Medicine, 2014.

[4] Yu T., Chen Z. Clinical research progress of huachansu injection in the treatment of middle and late stage hepatocellular carcinoma [J]. Journal of Integrative Medicine and Liver Diseases, 2017, 27(5):319 -321.

[5] Zheng Jiewen, Zhang Dan, Wu Jiarui, et al. Meta-analysis of adjuvant treatment of hepatocellular carcinoma with Addi injection [J]. Journal of pharmacoepidemiology, 2017, 26(8): 540-546.

[6] Sun Lin, Zhao Anju, Wei Yucheng,et al. Research progress of opium bile oil in the treatment of intermediate and advanced primary hepatocellular carcinoma[J]. Journal of Modern Traditional Chinese and Western Medicine,2017,26(15):1707 -1710.

[7] He NNA, Wang Dongmei, Zhang XJ. Postoperative efficacy and effect on serum immune factor level of primary hepatocellular carcinoma treated with the combination of tonifying the kidney and strengthening the spleen formula with Fu Zheng and tumor suppression formula[J]. Journal of Modern Integrative Chinese and Western Medicine,2017,26(21):2309 - 2311;2315.

[8] S Tao, Ning Xuejian, Yang Jianqing, et al. Effect of soft liver and bile soup on disease-free survival after hepatocellular carcinoma surgery[J]. Journal of Changchun University of Traditional Chinese Medicine,2015,31 (1):145 -148.

[9] Shi F-Y, Lou L-L, Xie K-K, et al. Reticulated Meta-analysis of Chinese medicine injection combined with hepatic artery cannulation embolization chemotherapy for hepatocellular carcinoma[J]. Chinese Journal of Experimental Formulary,2016,22(10):180 -187.

[10] Shi L, Hao JM, Hang JM, Yang Z. Effects of Bai Lian Hua Fei Tang on VEGF, liver function and AFP-L3 expression levels in patients with primary liver cancer after TACE[J]. Hainan Medicine, 2021,32(3):278-281.

[11] Ding K, Han F, Zhang R, Xu Q, Huang LJ, Shang JB. Feasibility analysis of gentian diarrhea of the liver soup combined with conventional western medicine in the treatment of embolization syndrome after TACE for primary liver cancer[J]. Practical Integrative Chinese and Western Medicine Clinical, 2018,18(04):105-107.

[12] Qian GW, Wang JF, Zhang YY,et al. Clinical study on the treatment of intermediate and advanced primary hepatocellular carcinoma with Pingxiao tablets combined with sorafenib[J]. Modern Drugs and Clinics,2019,34(2):419 -423.

[13] Feng LH, Chen YD, Zheng ZG, et al. Clinical efficacy of sorafenib combined with huachanin tablets in the treatment of intermediate and advanced primary hepatocellular carcinoma[J]. Chinese Journal of Cancer,2012,22(11):856 -859.

[14] Cucchetti A, Piscaglia F, Cescon M, et al. Cost-effective- ness of hepatic resection versus percutaneous radiofre- quency ablation for early hepatocellular carcinoma[J]. Journal of Hepatology,2013,59(2):300 -307.

[15] Mao K, Ye Z, Wang YQ, et al. Effect of ginseng mai injection on recurrent metastasis after radiofrequency ablation of hepatocellular carcinoma[J]. New Chinese medicine,2018,50(11):166 -168.

[16] Wang Ying. The effect of diaphragm and blood stasis soup with addition and subtraction on the chemotherapy effect and safety of patients with liver cancer (qi stagnation and blood stasis type)[J]. Inner Mongolia Medical Journal, 2018, 50(12):1484 -1485 .

[17] Xing Miao, Feng Guyi. Clinical efficacy of Fu Zheng Gu Ben Detoxification Formula combined with chemotherapy in the treatment of middle and late stage gastrointestinal tumors [J]. Chinese Traditional Medicine Science and Technology, 2019, 26(3):430 -432.

[18] Ge J, Zhu C-D. Effect of soft liver and bile soup on immune function of hepatocellular carcinoma cells treated with interventional combined with three-dimensional conformal radiotherapy [J]. Asia-Pacific Traditional Medicine, 2017, 13(20):148-149.

[19] Yang SR, Wang R, Chai LX, et al. Clinical observation of Addi injection combined with three-dimensional conformal radiotherapy for the treatment of mid- to late-stage primary liver cancer [J]. Shaanxi Traditional Chinese Medicine, 2017, 38(11):1495 -1496.